California Stem Cell Report: California Stem Cell Agency …

The California stem cell agency this morning announced that one of its early stage clinical trials has produced encouraging safety data in its search for a therapy that could eradicate AIDS.

Randy Mills, president of the stem cell agency, said,

Calimmune has a powerful scientific pedigree. Nobel Laureate David Baltimore, one of the firms founders, is chairman of the Calimmune board. He also once served on the governing board of the stem cell agency, formally known as the California Institute for Regenerative Medicine (CIRM).

The Calimmune Web site says that the company was formed in 2007 around stem cell technology discovered in the labs of Baltimore, while he was at Caltech, and Irvin Chen at the UCLA AIDS Institute in early 2000. Delaware state records show that the firm was incorporated in 2006.

In addition to Baltimore, another member of the the Calimmune board is Harry George, managing general partner of Solstice Capital, whose Tuscons office shares the same address as Calimmune.

Calimmune and the stem cell agency discussed the therapy at today's session of BIO2014 in San Diego, which is attended by about 15,000 persons in the biotech industry.

Here is a copy of the Calimmune contract with the stem cell agency.

Read more:

California Stem Cell Report: California Stem Cell Agency ...